AU2002325614A1 - Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances - Google Patents

Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances

Info

Publication number
AU2002325614A1
AU2002325614A1 AU2002325614A AU2002325614A AU2002325614A1 AU 2002325614 A1 AU2002325614 A1 AU 2002325614A1 AU 2002325614 A AU2002325614 A AU 2002325614A AU 2002325614 A AU2002325614 A AU 2002325614A AU 2002325614 A1 AU2002325614 A1 AU 2002325614A1
Authority
AU
Australia
Prior art keywords
production
lactic acid
active substances
pharmaceutically active
compounds containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002325614A
Inventor
Jens Kruse
Bodo Lachmann
Regina Lauer
Christian R. Noe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHARMACON-FORSCHUNG und BERATUNG GmbH
Original Assignee
Pharmacon Forschung & Beratung GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacon Forschung & Beratung GmbH filed Critical Pharmacon Forschung & Beratung GmbH
Publication of AU2002325614A1 publication Critical patent/AU2002325614A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/25—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
    • C07C69/68—Lactic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
AU2002325614A 2001-08-16 2002-08-16 Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances Abandoned AU2002325614A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ATA1288/01 2001-08-16
AT12882001 2001-08-16
PCT/AT2002/000247 WO2003016259A2 (en) 2001-08-16 2002-08-16 Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances

Publications (1)

Publication Number Publication Date
AU2002325614A1 true AU2002325614A1 (en) 2003-03-03

Family

ID=3688090

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002325614A Abandoned AU2002325614A1 (en) 2001-08-16 2002-08-16 Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances

Country Status (2)

Country Link
AU (1) AU2002325614A1 (en)
WO (1) WO2003016259A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL196384B1 (en) * 2005-01-11 2007-12-31 Ct Materialow Polimerowych I W New esters of non-steroid anti-inflammatory medicines and the method for their manufacture
EP2679222A1 (en) 2007-03-30 2014-01-01 Laccure Ab Use of oligomers of lactic acid in the treatment of gynaecological infections
RU2627470C2 (en) * 2012-07-16 2017-08-08 Лаккуре Аб Pharmaceutical compositions comprising oligomeric lactic acid
EP2810640A1 (en) * 2013-06-03 2014-12-10 Basf Se Esters of oligohydroxy carboxylic acids and their use
CA2986611C (en) 2015-06-15 2023-10-03 Nmd Pharma Aps Compounds for use in treating neuromuscular disorders
US11147788B2 (en) 2017-12-14 2021-10-19 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11730714B2 (en) 2017-12-14 2023-08-22 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2116347A (en) * 1937-08-25 1938-05-03 Dow Chemical Co Alpha-salicylo-aliphatic acid esters
DE1020324B (en) * 1954-12-17 1957-12-05 Boehringer Sohn Ingelheim Process for the production of ester-like lactic acid derivatives with a defined chain length and terminal ester, amide or nitrile group
US4216224A (en) * 1978-09-22 1980-08-05 Scott Eugene J Van Methods and compositions for treating psoriasis with retinoyl compounds
FR2658509B1 (en) * 1990-02-22 1992-06-12 Roussel Uclaf
AU668559B2 (en) * 1992-06-03 1996-05-09 Unilever Plc Improvements relating to cosmetic compositions
US5270331A (en) * 1993-01-26 1993-12-14 Pfizer, Inc. Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
JPH0959218A (en) * 1995-08-25 1997-03-04 Shimadzu Corp L-lactic acid oligomer derivative
US5880152A (en) * 1995-10-06 1999-03-09 Vertex Pharmaceuticals, Inc. Butyrate prodrugs derived from lactic acid
US5912269A (en) * 1996-04-30 1999-06-15 Vertex Pharmaceuticals, Inc. Butyrate prodrugs derived from lactic acid
US5883123A (en) * 1995-10-06 1999-03-16 Vertex Pharmaceuticals, Inc. Butyrate prodrugs derived from lactic acid
WO1997020812A1 (en) * 1995-12-04 1997-06-12 Advanced Polymer Systems, Inc. RETINYL ESTERS OF α-HYDROXY ACIDS FOR TOPICAL IMPROVEMENT OF SKIN FUNCTION AND APPEARANCE
AU6015700A (en) * 1999-07-19 2001-02-05 Shionogi & Co., Ltd. P-terphenyl compounds bearing acyloxymethoxycarbonyl side chains
JP2002265420A (en) * 2001-03-13 2002-09-18 Tendou Seiyaku Kk Linear oligolactic acid ester

Also Published As

Publication number Publication date
WO2003016259A2 (en) 2003-02-27
WO2003016259A3 (en) 2003-09-12

Similar Documents

Publication Publication Date Title
AU2001278771A1 (en) Carboxylic acid derivatives, process for producing the same and drugs containingthe same as the active ingredient
AU2002219174A1 (en) Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof
AU2003233010A1 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
AU2002337047A1 (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
AU2002213977A1 (en) Novel anticholinergics, method for the production thereof and use thereof as medicaments
AU2002219173A1 (en) Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
AU2003282094A1 (en) Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments
AU2002231688A1 (en) Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
AU2001284021A1 (en) Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof
HK1081965A1 (en) Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
AU6436800A (en) Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
AU2002238855A1 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
HUP0400155A3 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
AU2001241056A1 (en) Spiro compounds, process for preparing the same and use thereof as drugs
AU2003203170A1 (en) Nitrogenous heterocyclic compounds, process for preparation of the same and use thereof
AU2001234107A1 (en) Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
AU2001263835A1 (en) Haemostatically active preparation containing vWF and method for the production thereof
AU2002325614A1 (en) Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances
AU3825700A (en) Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
AU2001258200A1 (en) Synthetic derivatives of lunularic acid, medicaments containing said compounds, method for producing the lunularic acid derivatives and the use thereof
AU2003257608A1 (en) Inorganic compound containing active oxygen and process for producing the same
AU2001241067A1 (en) Omega-substituted phenyl-prostaglandin e-alcohols, process for producing the same and drugs containing the same as the active ingredient
AU2001252254A1 (en) 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparationthereof and use thereof
AU2002363776A1 (en) Carboxylic acid derivative compounds and drugs containing the same as the active ingredient
AU2003229863A1 (en) Porphyrin derivatives, method for the production thereof, pharmaceutical compositions and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase